Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
… led to 43.2% clinical remission in an Emirati CD cohort, while tofacitinib achieved clinical remission rates of 56.4% and 61.1% at 52 week…
…strongly suspected, and therapy with colchicine, adalimumab and mycophenolate mofetil was initiated. The patient improved significantly and was disch…
…otrexate and Sulfasalazine as well as biological agents such as Adalimumab and Rituximab. Here, we therefore compare real-world experience…
…ucing his pre-existing immunosuppression (ceasing methotrexate, leflunomide and oral prednisolone). A repeat MRI brain demonstrated signifi…
… systemic immunosuppression (oral steroids, methotrexate and/or adalimumab). 2 cases had recurrence of anterior uveitis.Paediatric uveitis…
…phenotypes were analysed by flow cytometry. Treatments included adalimumab (anti-TNFα), secukinumab (anti-IL-17A), and/or 1,25(OH) 2D3, ap…
…mmol/L) and acute flaccid paralysis after his third intravenous tocilizumab infusion. He had no prior neurological or electrolyte disturban…
…s.She was treated with oral steroids, mycophenolate mofetil and adalimumab. At 6 months she underwent transfemoral coronary, pulmonary, pe…
…uding adalimumab, infliximab and vedolizumab, prior to starting Ustekinumab. 12/21 patients stopped treatment because of poor response. 4/1…
…dalimumab,50% Vedolimumab,66%(n=4) had Ustekinumab,66%(n=4) had Azathioprine. All patients received UPA as monotherapy.UPA induction was adm…
…Upadacitinib (UPA) is a novel orally administered small molecule drug that w…
…29 children had significant IBD clinical symptoms when starting Ustekinumab. 16/20 (80%) saw some improvements at 3 months. At 6 months 8/2…